Acadia Pharmaceuticals | ACAD - Eps Ganancias Por Acción


Fiscal Calendario Real Consenso Anterior Fecha
FY2026Q3 Sep/2026 0.31 0.13 0.42 Nov/04
FY2026Q2 Jun/2026 0.18 0.06 0.16 Aug/04
FY2026Q1 Mar/2026 0.02 0.07 0.11 May/06
FY2025Q4 Dec/2025 1.60 0.14 0.86 Feb/25
FY2025Q3 Sep/2025 0.42 0.14 0.20 Nov/05




Eps Cambio Fecha
Acadia Pharmaceuticals USD 0.31 0.13 2026-09
ALKERMES USD 0.09 0.09 2026-09
Alnylam Pharmaceuticals USD 16.26 14.42 2026-09
Biogen USD 2.62 0.98 2026-09
BioMarin Pharmaceutical USD 0.23 0.97 2026-09
Bristol-Myers Squibb USD 1.35 0.69 2026-09
Cara Therapeutics USD -0.72 0.14 2026-03
Corcept Therapeutics USD 1.01 0.65 2026-09
Cytokinetics USD -1.37 0.13 2026-09
Eisai JPY 41.47 23.24 2026-09
Eli Lilly USD 7.48 0.9 2026-09
Incyte USD -3.6 6.69 2026-09
J&J USD 2.7 0.2 2026-09
Moderna USD 0.38 2.35 2026-09
Neurocrine Biosciences USD 3.29 0.44 2026-09
Pfizer USD 0.87 0.1 2026-09
Prothena USD -0.36 0.96 2026-06
PTC Therapeutics USD -0.62 1.54 2026-09
Sarepta Therapeutics USD 0.13 0.51 2026-09
Ultragenyx Pharmaceutical USD -1.16 0.26 2026-09
Vanda Pharmaceuticals USD -0.09 0 2024-12
Vertex Pharmaceuticals USD 4.76 0.03 2026-09